Tingsheng Medical and GE Healthcare Forge Strategic Alliance to Advance Intracardiac Echocardiography

November 6, 2024, in the morning,Jiangsu TINGSN Technology Co.,Ltd.(TINGSN) andGE Healthcare(GE Healthcare) signed in ShanghaiStrategic CooperationAgreement. Zhang Dongyu, Chairman of TINGSN, Wang Jing, General Manager, Wu Jian, Partner, Xu Yong, Regulatory Director, Zhang Yihao, President and CEO of GE Healthcare China, Chen Chuhui, Vice President of GE Healthcare China and General Manager of Advanced Visualization and Diagnosis & Treatment Business, Wang Lei, Vice President of GE Healthcare China and General Manager of Ultrasound Business, and Wang Jun, Director of Cardiac Ultrasound Products of GE Healthcare Ultrasound Business, attended the signing ceremony.

TINGSN, as a company at the forefront of technological innovation, has demonstrated extraordinary strength and potential in the ultrasound field. The TINGSN Sonic Eyes 10, a disposable intracardiac echocardiography diagnostic catheter independently developed and produced by TINGSN, obtained NMPA registration on November 28, 2023. It is an innovative medical device approved by the NMPA and also the first intracardiac echocardiography diagnostic catheter independently developed and produced in China. After its market launch, the product has received widespread attention and recognition in China’s cardiovascular field. Currently, it has been applied in clinical practice in over 160 hospitals and has been highly praised by clinicians.

As a giant in the global medical industry, GE Healthcare has long been renowned in the field of ultrasound diagnostic technology, boasting deep technical expertise and extensive practical experience. Vivid iq, as GE's flagship portable ultrasound diagnostic system, inherits the profound technical foundation of GE Vivid, incorporates more innovative echocardiography technology, and features excellent ergonomic design, powerful cardiac clinical applications, and intelligent operational processes. This has enabled Vivid iq to gradually secure a significant position in the international medical market, providing precise diagnostic support to countless medical institutions worldwide.

The official signing of this strategic cooperation agreement is based on the profound insights and strategic planning of both parties regarding the development trends in the intracardiac echocardiography (ICE) field. TINGSN Technology and GE Healthcare will fully leverage their respective strengths to adapt TINGSN's ICE catheter with GE Healthcare’s Vivid iq ultrasound diagnostic system. This collaboration aims to rapidly expand TINGSN’s ICE catheter market share in China and prepare for its entry into international markets, while also broadening the depth and breadth of GE Healthcare’s Vivid iq ultrasound diagnostic system applications in the cardiovascular field, further solidifying its leading position in the global medical equipment market. The signing of this strategic cooperation agreement not only injects strong momentum into the development of TINGSN Technology and GE Healthcare but also sets a new benchmark for the global intracardiac echocardiography field. TINGSN Technology will seize this strategic cooperation as an important opportunity to move forward hand-in-hand with GE Healthcare. Through technical complementarity and joint promotion, both parties will further enhance their influence in the global medical field, bring more benefits to patients with heart diseases, and drive medical technology toward higher levels!